Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Union Korea Pharm Co. Ltd. (080720:KRX), powered by AI.
Union Korea Pharm Co. Ltd. is currently trading at ₩2,725. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Union Korea Pharm Co. Ltd. on Alpha Lenz.
Union Korea Pharm Co. Ltd.'s P/E ratio is -2.1.
“Union Korea Pharm Co. Ltd. trades at a P/E of -2.1 (undervalued) with strong ROE of 420.7%.”
Ask for details →Union Korea Pharm Co. Ltd. is a biotechnology and pharmaceutical company based in South Korea. Its primary function is the research, development, production, and sale of pharmaceutical products aimed at addressing a wide range of medical needs. The company specializes in producing both prescription and over-the-counter medications, focusing on therapeutics for conditions such as cardiovascular diseases, antibiotics, and biopharmaceutical innovations. Union Korea Pharm Co. Ltd. influences the healthcare sector significantly through its commitment to advancing medical treatment standards and improving patient outcomes. With a robust focus on innovation and technology, the company plays a crucial role in the pharmaceutical industry, contributing to the growth and development of healthcare solutions in domestic and international markets.
“Union Korea Pharm Co. Ltd. trades at a P/E of -2.1 (undervalued) with strong ROE of 420.7%.”
Ask for details →Union Korea Pharm Co. Ltd. (ticker: 080720) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 166 employees. Market cap is $64.7B.
The current price is ₩2,725 with a P/E ratio of -2.1x and P/B of -2.82x.
ROE is 420.69% and operating margin is -47.37%. Annual revenue is $36.4B.